Functional cooperation of SMCTs and URAT1 for renal reabsorption transport of urate

Drug Metabolism and Pharmacokinetics

Volumn 28, Issue 2, 2013, Pages 153-158

  Lu, Yang ^a   Nakanishi, Takeo ^a   Tamai, Ikumi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Protein protein interaction; SMCT; Transporter; URAT1; Urate; Uric acid

Indexed keywords

MEMBRANE PROTEIN; NICOTINIC ACID; SODIUM COUPLED MONOCARBOXYLATE TRANSPORTER; SODIUM ION; UNCLASSIFIED DRUG; URATE; URATE TRANSPORTER 1;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; KIDNEY TUBULE ABSORPTION; NONHUMAN; OOCYTE; PROTEIN FUNCTION; XENOPUS;

EID: 84876748933     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.DMPK-12-RG-070     Document Type: Article

References (35)

1. Waring, W. S., Webb, D. J. and Maxwell, S. R. J.: Systemic urate administration increases serum antioxidant capacity in healthy volunteers. J. Cardiovasc. Pharmacol., 38: 365-371 (2001).
2. Maxwell, S. R. J., Thomason, H., Sandler, D., Leguen, C., Baxter, M. A., Thorpe, G. H. G., Jones, A. F. and Barnett, A. H.: Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus. Eur. J. Clin. Invest., 27: 484-490 (1997).
3. Hisatome, I., Tsuboi, M. and Shigemasa, C.: Renal hypouricemia. Nippon Rinsho, 54: 3337-3342 (1996).
4. Tykarski, A.: Mechanism of hypouricemia in Hodgkin's disease. Nephron, 50: 217-219 (1988).
5. Kutzing, M. K. and Firestein, B. L.: Altered urate levels and disease states. J. Pharmacol. Exp. Ther., 324: 1-7 (2008).
6. Sato, M., Mamada, H., Anzai, N., Shirasaka, Y., Nakanishi, T. and Tamai, I.: Renal secretion of urate by organic anion transporter 2 (OAT2/ SLC22A7) in human. Biol. Pharm. Bull., 33: 498-503 (2010).
7. Hediger, M. A., Johnson, R. J., Miyazaki, H. and Endou, H.: Molecular physiology of urate transport. Physiology (Bethesda), 20: 125-133 (2005).
8. Yamanaka, H.: Japanese guideline for the management of hyperuricemia and gout: second edition. Nucleos. Nucleot. Nucl., 30: 1018-1029 (2011).
9. Choi, H. K., Mount, D. B. and Reginato, A. M.: Pathogenesis of gout. Ann. Intern. Med., 143: 499-516 (2005).
10. So, A. and Thorens, B.: Urate transport and disease. J. Clin. Invest., 120: 1791-1799 (2010).
11. Ioachimescu, A. G., Brennan, D. M., Hoar, B. M., Hazen, S. L. and Hoogwerf, B. J.: Serum urate is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study. Arthritis Rheum., 58: 623-630 (2008).
12. Feig, D. I., Kang, D. H. and Johnson, R. J.: Urate and cardiovascular risk. N. Engl. J. Med., 359: 1811-1821 (2008).
13. Johnson, R. J., Kanbay, M., Kang, D. H., Sanchez-Lozada, L. G. and Feig, D.: Urate: a clinically useful marker to distinguish preeclampsia from gestational hypertension. Hypertension, 58: 704-708 (2011).
14. Gagliardi, A. C. M., Miname, M. H. and Santos, R. D.: Urate: a marker of increased cardiovascular risk. Atherosclerosis, 202: 11-17 (2009).
15. Constantinescu, R. and Zetterberg, H.: Urate as a marker of development and progression in Parkinson's disease. Drug. Today, 47: 369-380 (2011).
16. Sato, M., Wakayama, T., Mamada, H., Shirasaka, Y., Nakanishi, T. And Tamai, I.: Identification and functional characterization of urate transporter Urat1 (Slc22a12) in rats. Biochim. Biophys. Acta, 1808: 1441-1447 (2011).
17. Hosomi, A., Nakanishi, T., Fujita, T. and Tamai, I.: Extra-renal elimination of urate via intestinal efflux transporter BCRP/ABCG2. PLoS ONE, 7: e30456 (2012).
18. Enomoto, A., Kimura, H., Chairoungdua, A., Shigeta, Y., Jutabha, P., Cha, S. H., Hosoyamada, M., Takeda, M., Sekine, T., Igarashi, T., Matsuo, H., Kikuchi, Y., Oda, T., Ichida, K., Hosoya, T., Shimokata, K., Niwa, T., Kanai, Y. and Endou, H.: Molecular identification of a renal urate-anion exchanger that regulates blood urate levels. Nature, 417: 447-452 (2002).
19. Dinour, D., Bahn, A., Ganon, L., Ron, R., Geifman-Holtzman, O., Knecht, A., Gafter, U., Rachamimov, R., Sela, B., Burckhardt, G. and Holtzman, E. J.: URAT1 mutations cause renal hypouricemia type 1 in Iraqi Jews. Nephrol. Dial. Transplant., 26: 2175-2181 (2011).
20. Komatsuda, A., Iwamoto, K., Wakui, H., Sawada, K. and Yamaguchi, A.: Analysis of mutations in the urate transporter 1 (URAT1) gene of Japanese patients with hypouricemia in northern Japan and review of the literature. Renal Failure, 28: 223-227 (2006).
21. Ichida, K., Hosoyamada, M., Hisatome, I., Enomoto, A., Hikita, M., Encou, H. and Hosoya, T.: Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion. J. Am. Soc. Nephrol., 15: 164-173 (2004).
22. Iwanaga, T., Sato, M., Maeda, T., Ogihara, T. and Tamai, I.: Concentration-dependent mode of interaction of angiotensin II. J. Pharmacol. Exp. Ther., 320: 211-217 (2007).
23. Sato, M., Iwanaga, T., Mamada, H., Ogihara, T., Yabuuchi, H., Maeda, T. and Tamai, I.: Involvement of urate transporters in alternation of serum urate level by angiotensin II receptor blockers. Pharm. Res., 25: 639-646 (2008).
24. Li, Y., Sato, M., Yanagisawa, Y., Mamada, H., Fukushi, A., Mikami, K., Shirasaka, Y. and Tamai, I.: Effects of angiotensin II receptor blockers on renal handling of urate in rats. Drug Metab. Pharmacokinet., 23: 263-270 (2008).
25. +-coupled transporter for short-chain fatty acids. J. Biol. Chem., 279: 13293-13296 (2004).
26. Gopal, E., Umapathy, N. S., Martin, P. M., Ananth, S., Gnana-Prakasam, J. P., Becker, H., Wagner, C. A., Ganapathy, V. and Prasad, P. D.: Cloning and functional characterization of human SMCT2 (SLC5A12) and expression pattern of the transporter in kidney. Biochim. Biophys. Acta, 1768: 2690-2697 (2007).
27. Thangaraju, M., Ananth, S., Martin, P. M., Roon, P., Smith, S. B., Sterneck, E., Prasad, P. D. and Ganapathy, V.: c/ebpźδ Null mouse as a model for the double knock-out of slc5a8 and slc5a12 in kidney. J. Biol. Chem., 281: 26769-26773 (2006).
28. Anzai, N., Jutabha, P., Amonpatumrat-Takahashi, S. and Sakurai, H.: Recent advances in renal urate transport: characterization of candidate transporters indicated by genome-wide association studies. Clin. Exp. Nephrol., 16: 89-95 (2012).
29. Anzai, N., Kanai, Y. and Endou, H.: New insights into renal transport of urate. Curr. Opin. Rheumatol., 19: 151-157 (2007).
30. Mount, D. B., Kwon, C. Y. and Zandi-Nejad, K.: Renal urate transport. Rheum. Dis. Clin. North Am., 32: 313-331 (2006).
31. Anzai, N., Miyazaki, H., Noshiro, R., Khamdang, S., Chairoungdua, A., Shin, H., Enomoto, A., Sakamoto, S., Hirata, T., Tomita, K., Kanai, Y. and Endou, H.: The multivalent PDZ domain-containing protein PDZK1 regulates transport activity of renal urate-anion exchanger URAT1 via its C terminus. J. Biol. Chem., 279: 45942-45950 (2004).
32. Iwanaga, T., Kobayashi, D., Hirayama, M., Maeda, T. and Tamai, I.: Involvement of urate transporter in increased renal clearance of the xanthine oxidase inhibitor oxypurinol induced by a uricosuric agent, benzbromarone. Drug Metab. Dispos., 33: 1791-1795 (2005).
33. Gopal, E., Miyauchi, S., Martin, P. M., Ananth, S., Roon, P., Smith, S. B. and Ganapathy, V.: Transport of nicotinate and structurally related compounds by human SMCT1 (SLC5A8) and its relevance to drug transport in the mammalian intestinal tract. Pharm. Res., 24: 575-584 (2007).
34. Anzai, N., Jutabha, P. and Endou, H.: Renal solute transporters and their relevance to serum urate disorder. Curr. Hypertens. Rep., 6: 148-154 (2010).
35. Ichida, K.: What lies behind serum urate concentration? Insights from genetic and genomic studies. Genome Med., 1: 118 (2009).